# Larimar Therapeutics, Inc.: Form 8-K, filed Feb 5, 2020

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2020-02-05
- Accepted by EDGAR: Feb 5, 2020, 16:30 ET
- Period: 2020-02-05
- Accession: 0001193125-20-025413
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312520025413/d834605d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312520025413/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312520025413/d834605d8k.htm

Filed Feb 5, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-025413. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
